Skip to main content
. 2013 Oct 9;15(12):905–909. doi: 10.1111/jch.12206

Table 1.

Clinical Data of Study Population

Variable No LVH (n=41) LVH (n=26) Total (N=67)
Women, No. (%) 17 (41.46) 6 (23.08) 23 (34.33)
Men, No. (%) 24 (58.54) 20 (76.92) 44 (65.67)
Age, median (IQR), y 14 (12–16) 14.5 (12–17) 14 (12–16)
BMI, median (IQR), kg/m2 a 21.6 (19.8–25.8) 28 (23.4–29.8) 23.9 (20.4–28.4)
wBPSD, median (IQR), mm Hg 10.8 (9.3–12.4) 11.6 (10–13.6) 11.2 (9.5–13.2)
24‐H ARVBP, median (IQR), mm Hg 8.6 (7.1–10.2) 8.5 (7.6–10.6) 8.6 (7.3–10.5)
24‐H aSBP, median (IQR), mm Hga 117 (105–124) 129 (117–133) 120 (111–129)
24‐H SBP load, No. (%) 19.5 (8.6–34.5) 55.6 (31.7–6) 32 (13–55.3)
Normotensive, No. (%) 18 (43.9) 3 (11.5) 21 (31.3)
Ambulatory prehypertension, No. (%) 10 (24.4) 3 (11.5) 13 (19.40)
Ambulatory hypertension, No. (%) 2 (4.9) 1 (3.8) 3 (4.5)
Severe ambulatory hypertension, No. (%)a 5 (12.2) 16 (61.5) 21 (31.3)
White‐coat hypertension, No. (%) 6 (14.6) 3 (11.5) 9 (13.4)

Abbreviations: ARVBP, real average variability of blood pressure; BMI, body mass index; aSBP, ambulatory systolic blood pressure; IQR, interquartile range; LVH, left ventricular hypertrophy; SBP, systolic blood pressure; wBPSD, weighted standard deviation of blood pressure.

a

P<.05.